Navigation Links
Herley's Israeli Subsidiary, GMI Eyal, is Selected to Provide Complex Microwave Switch Assemblies for a U.S. Customer
Date:6/4/2009

LANCASTER, Pa., June 4 /PRNewswire-FirstCall/ -- Herley Industries, Inc. (Nasdaq: HRLY) announced today that its GMI Eyal subsidiary, in Israel, has recently received contracts valued at approximately $4 million to provide various complex microwave switch assemblies for a U.S. customer. These are follow-on awards for an existing customer and program. The hardware will be used for ongoing upgrades to a U.S. aircraft.

Herley Industries, Inc. acquired Eyal Microwave Industries, ("EMI") last year to gain market share in command, control, communications, computers, intelligence, surveillance, and reconnaissance (C4ISR) systems.

Myron Levy, Herley's Chairman and CEO, commented, "GMI Eyal is proving to be a good acquisition for Herley, with steady growth and good performance. Yonah Adelman is General Manager for both of our Israeli manufacturing operations. Yonah and his team have built a strong business relationship with this customer, and we believe that we will see additional contract awards within the next few months and in the future."

Herley Industries, Inc. is a leader in the design, development and manufacture of microwave technology solutions for the defense, aerospace and medical industries worldwide. Based in Lancaster, PA, Herley has seven manufacturing locations and approximately 1000 employees. Additional information about the company can be found on the Internet at www.herley.com.

    For information at Herley contact:                   Tel: (717) 735-8117
    Peg Guzzetti                                         www.herley.com
    Investor Relations

Safe Harbor Statement - Except for the historical information contained herein, this release may contain forward-looking statements. Such statements are inherently subject to risks and uncertainties. When used in this report, words such as "anticipated," "believes," "could," "estimates," "expects," "may," "plans," "potential" and "intends" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the belief of the Company's management, as well as assumptions made by and information currently available to the Company's management. The Company's results could differ materially based on various factors, including, but not limited to, competitive factors and pricing pressures, changes in legal and regulatory requirements, cancellation or deferral of customer orders, technological change or difficulties, difficulties in the timely development of new products, difficulties in manufacturing, commercialization and trade difficulties, and current economic conditions. The Company undertakes no obligation to update forward-looking statements as a result of future events or developments.


'/>"/>
SOURCE Herley Industries, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Autism Support Network and the Israeli Society for Autistic Children Form International Alliance
2. Johnson & Johnson Announces Receipt of Israeli Antitrust Approval for Acquisition of Omrix
3. Canadian, German, Israeli, New Zealand, U.K and U.S. Companies Selected to Make Company Presentations at AdvaMed 2008
4. US-Israeli-Palestinian collaboration to advance Alzheimers disease research
5. Israeli study finds obstructive sleep apnea is health factor from day 1
6. VCU Massey Cancer Center to partner with Israeli biotech firm
7. The development of a language in space -- Israeli Sign Language
8. Beam of Light is ray of hope for Israeli-Jordanian cooperation
9. Chief Technology Officer for Baxa Corporations Subsidiary, FHT, Inc., Presents at the Fourth Annual unSUMMIT for Bedside Barcoding in Tampa, Florida
10. A Better Tomorrow Treatment Center Inc., a Forterus Subsidiary, to Be Featured On A & E Television Networks Intervention Program
11. Sinobiopharma Reports Highlights of Third Quarter Results for Its Operating Subsidiary, Dong Ying China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , ... mock evacuation of the facility as part of a disaster drill on October 3rd. ... EMS and Shelton City Emergency Manager, as well as the Connecticut Long Term ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: